Assoc Prof Alan Fraser

Alan Fraser has written over 100 research papers. His current interests are primarily in the interaction between diet and genetics in Crohn's disease.

He has an active role in research with the Nutragenomics group at the University of Auckland and also with the Department of Molecular Biology.

View Alan's Profile

Articles and Publications

Fraser AG, Rosalki SB, Gamble GG, Pounder RE. Inter-individual and intraindividual variability of ethanol concentration-time profiles: comparison of ethanol ingestion before or after an evening meal. Br J Clin Pharmacol 1995; 40:387- 392.

Fraser AG, Ali MR, McCullough S, Haystead A. Diagnostic tests for Helicobacter pylori - can they help select patients for endoscopy? NZ Med Journal 1996; 109: 95-8.

Fraser AG, Scragg R, Metcalf P, McCullough S, Yeates NJ. Prevalence of Helicobacter pylori in different ethnic groups in New Zealand children and adults.
Aust NZ J Med 1996; 26:646-51 (with editorial).

Fraser AG, Moore L, Berry S, Arroll B. Eradication treatment for Helicobacter pylori in general practice. NZ Med Journal 1996; 109: 422-4.

Schmid J, Fraser AG, Hollis B, O'Toole P. Ethnic tropism of DNA fingerprints of
Helicobacter pylori. Infection and Immunity 1997; 65: 3708-12.

Fraser AG, Peng S-L, Jass JR. Intestinal metaplasia subtypes and Helicobacter
infection - a comparison of ethnic groups in New Zealand. J Gastro Hepatol 1998; 13: 560-565.

Fraser AG, Schreuder V, Chua L, Moore L. Follow-up after successful eradication of H.pylori - symptoms and re-infection. J Gastro Hepatol 1998; 13:

Fraser AG, Moore L, Hackett M, Hollis B. H.pylori treatment and antibiotic
susceptibility: results of a five-year audit. Aust NZ J Med 1999; 29: 512-517.

Fraser AG, Morton RP, Gillebrand J. Presumed laryngo-pharyngeal reflux;
investigate or treat. J Otolaryngology 2000; 114: 441-47.

Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the
treatment of inflammatory bowel disease: a 30 year review. Gut 2002; 50: 485-

Fraser AG, Morton D, McGovern D, Travis S, Jewell DP. The efficacy of
methotrexate for maintaining remission in inflammatory bowel disease. Aliment
Pharmacol Therap 2002; 16: 693-697.

Fraser AG, Orchard TR, Robinson EM, Jewell DP. Long-term risk of malignancy
after treatment of inflammatory bowel disease with azathioprine. Aliment
Pharmacol Therap 2002; 16: 1225-1232.

Fraser AG, Warren BF, Chandrapala R, Jewell DP. Microscopic colitis: a clinical
and pathological review. Scand J Gastroenterol 2002; 11: 1241-45.

Fraser AG. Helicobacter pylori: a historical perspective 1983-2003. NZ Med
2004; 117: 1194.

Fraser AG, Kandiel A, Korelitz BI, Brensinger C, Lewis JD. Increased risk of
lymphoma among inflammatory bowel disease patients treated with azathioprine
and 6-mercaptopurine. Gut 2005; 54, 1121-1125.

Leung E, Hong J, Fraser AG, Merriman TR, Vishnu P, Abbott WGH, Krissansen
GW. Polymorphisms of CARD15/NOD2 and CD14 genes in New Zealand
Crohn's disease patients. Immunology and Cell Biology 2005; 83: 498-503.